Eric Fenstad is a Cardiology physician affiliated with Minneapolis Heart Institute Foundation. OpenAlex indexes 56 publications with 720 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2024 S 6th St
Brainerd, MN 564014529
Telephone
218-855-5280Provider last certified this registry record 8 May 2025.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20241 payment
- Bayer Healthcare Pharmaceuticals Inc.Program year20231 payment
- Edwards Lifesciences CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.7%Statin17.4%Rosuvastatin Calcium60%Atorvastatin Calcium34%Simvastatin5%Pravastatin Sodium2%Part D<11 patientsBeta blocker17%Metoprolol Succinate45%Carvedilol22%Sotalol14%Metoprolol Tartrate13%Atenolol3%Propranolol Hcl2%Part D<11 patients+ 17 more classes in this area
Blood & clotting
13.5%Factor Xa inhibitor9.9%Eliquis53%Xarelto47%Part D≥70 patientsP2Y12 inhibitor3.1%Clopidogrel76%Brilinta17%Prasugrel Hcl7%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.4%SGLT2 inhibitor1.4%Jardiance100%Part D≥13 patientsPotassium supplement1%Potassium Chloride100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pulmonary Hypertension in the Setting of Hemodialysis Arteriovenous Fistulas: Natural History and Outcomes
The Journal of Heart and Lung Transplantation
2022 - PULMONARY HYPERTENSION WITH SEVERE AORTIC STENOSIS: HEMODYNAMIC CHARACTERISTICS BEFORE AND AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
Journal of the American College of Cardiology
2020 - Pulmonary Hypertension in Rural Minnesota: Prevalence and Clinical Classification
The Journal of Heart and Lung Transplantation
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanouil Brilakis, MD
Minneapolis Heart Institute Foundation
Yader Sandoval Pichardo, MD
Minneapolis Heart Institute Foundation
Robert Hauser, MD
Minneapolis Heart Institute Foundation
Rizwan Attia, MBCHB
Minneapolis Heart Institute Foundation
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”